Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 74Gastrointestinal 22Breast 21Thoracic 19Head & Neck 19Genitourinary 18Dermatologic 8Lymphoid 5Sarcoma 4CNS 4Plasma cell 2Other hematologic neoplasm 2Other solid neoplasm 1Other 1Myeloid 1Endocrine 1Classical hematology 1

Conditions

Advanced Solid Tumors 35Advanced Solid Tumor 22Solid Tumors 17Mesothelioma 16Solid Tumor 12Mesothelioma, Malignant 11Hematopoietic and Lymphatic System Neoplasm 10Ovarian Neoplasms 7Solid Tumor, Adult 5Pancreatic Neoplasms 5Malignant Solid Neoplasm 5Solid Tumours 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Advanced Solid Tumour 4Stomach Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma 3Kidney Neoplasms 3Advanced or Metastatic Solid Tumors 3Advanced Malignant Solid Tumors 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Thymus Neoplasms 2Solid Tumor Malignancies 2Solid Tumor Cancer 2Retinoblastoma 2Rectal Neoplasms 2Neoplasms 2Metastatic Solid Tumors 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Other solid neoplasm × 30 days × Clear all
NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

M.D. Anderson Cancer Center

Phase 2 Suspended
140 enrolled
EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡